NXT Ventures — 2016 Investments

2 investments dated 2016 · listed companies and verified rows first · show all

Intarcia TherapeuticsDec 2016

Biopharmaceutical company developing innovative therapies for chronic diseases using proprietary drug delivery systems.

BiotechBoston, US

James Ahlers(Executive Officer)John Yee(Executive Officer)Sunita Zalani(Executive Officer)Raymond T. Keane(Executive Officer)Thomas Alessi(Executive Officer)Owen Hughes, Jr.(Executive Officer)

Co-investorsBay City Capital Cycad Group LLC Foresite Capital

Netranetra.io inMay 2016

Boston, US

Richard Lee(Executive Officer, Director)Shashi Kant(Executive Officer, Director)

BoardHambleton Lord(Director)Raymond Chang(Director)

Co-investorsBantam Group Techstars Unicorn India Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.